Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders including Alzheimer’s disease (AD) which modulate immune competence in neurons and glia cells. DZNE
More
Eisai Co., Ltd. announced today that it has obtained the manufacturing and
EA Pharma Co., Ltd. and its parent company Eisai Co., Ltd. announced
Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration
MoreEA Pharma Co., Ltd. and its parent company Eisai Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare
MoreEisai Co., Ltd. announced today that it has obtained the manufacturing and marketing approval in Japan for its in-house discovered
More
